GlassScriptPhysician profile
Antonios Mammis
NPI 1417111360
$43,892.80
in general payments reported to CMS, 2019-2025
31 companies · $4,624 in 2025
The $4,624 reported for 2025 was more than what 80% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $4,797 · 2021: $5,108 · 2022: $4,513 · 2023: $3,854 · 2024: $4,822 · 2025: $4,624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Travel and Lodging: $1,307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,994.14 |
| Travel and Lodging | $1,306.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $9,148.34 | 2019-2025 | General - Dbs, Intracept, General - Pain Management |
| Medtronic USA, INC. | $7,159.13 | 2019-2020 | |
| Abbott Laboratories | $6,785.91 | 2019-2025 | Infinity, Proclaim, Xience Skypoint |
| Nevro Corp. | $6,230.94 | 2019-2024 | Senza |
| Baxter Healthcare | $2,988.33 | 2019-2025 | Actifuse |
| Medtronic, INC. | $2,463.32 | 2021-2025 | Percept PC Brainsense, Intellis Adaptivestim, Synchromedii |
| Globus Medical, INC. | $1,875.60 | 2019-2025 | Senza, Reline, Quartex |
| Saluda Medical Americas, INC. | $1,853.61 | 2023-2025 | Evoke, Evoke Scs |
| Stryker Corporation | $1,271.46 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $919.63 | 2020-2022 | |
| Relievant Medsystems, INC. | $505.73 | 2021-2022 | |
| Stimwave Technologies Incorporated | $427.78 | 2019-2021 | |
| Nuvasive, INC. | $422.47 | 2020-2022 | |
| Si-Bone, INC. | $422.14 | 2020-2021 | |
| Spr Therapeutics, INC | $176.82 | 2021-2025 | Sprint Pns System |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $165.96 | 2025 | Other - Miscellaneous |
| Insightec,INC | $145.51 | 2024 | Exablate |
| Organogenesis INC. | $131.17 | 2023 | Puraply |
| Bioventus LLC | $123.23 | 2023 | Stimrouter Implantable Kit |
| Mml US, INC. | $118.21 | 2025 | Reactiv8 |
| Orthofix Medical, INC. | $118.15 | 2024 | Spinal-Stim |
| Spinal Elements, INC. | $113.84 | 2022 | |
| Biocomposites INC | $111.33 | 2025 | Stimulan |
| Intrinsic Therapeutics | $34.83 | 2021 | |
| Abbvie INC. | $34.03 | 2025 | |
| Cala Health, INC. | $28.37 | 2025 | Cala Kiq |
| Innovation Technologies INC | $27.41 | 2025 | Irrisept |
| Dynavax Technologies Corporation | $25.04 | 2023 | Heplisav-B |
| Highridge Medical LLC | $23.57 | 2024 | Mobi-C Plug & Fit US |
| Neuros Medical, INC. | $22.54 | 2025 | Altius |
| Glaxosmithkline, LLC. | $18.40 | 2025 | Trelegy Ellipta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonios Mammis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.